semaglutide mash approval CDSCO Clears Wegovy for — India's First GLP-1 for Liver Disease, India's drug regulator CDSCO approved Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on Novo Nordisk leads MASH therapeutic

106 ZnT transporters are also expected to contain a conserved zinc-binding site on TM helices II and V, with critical residues determining their metal specificity

"This supports more individualized counseling and surveillance rather than a generic message that weight loss itself inevitably causes hair loss," he said

mean, pollution everywhere

Like its once-weekly counterpart, the pill is also approved to reduce cardiovascular risk, reinforcing the idea that GLP-1 medications are now viewed as long-term metabolic therapies rather than short-term weight-loss tools

Case Study: Transforming Health with GLP-1 Injections in Lafayette, LA At MinuteMed Walk-In Clinic in Lafayette, LA , we are dedicated to offering innovative, evidence-based treatments that improve lives